Vaxart
(OTC) VXRT
Vaxart Financials at a Glance
Market Cap
$136.15M
Revenue (TTM)
$255.61M
Net Income (TTM)
$37.10M
EPS (TTM)
$0.15
P/E Ratio
3.77
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Price
$0.57
Volume
177,401
Open
$0.57
Price
$0.57
Volume
177,401
Open
$0.57
Previous Close
$0.57
Daily Range
$0.55 - $0.58
52-Week Range
$0.26 - $0.84
Estimated Earnings Date
May 7, 2026
Dividend
$0.00
Beta (Volatility)
1.70 (High)
Price
$0.57
Volume
177,401
Open
$0.57
Previous Close
$0.57
Daily Range
$0.55 - $0.58
52-Week Range
$0.26 - $0.84
Estimated Earnings Date
May 7, 2026
VXRT News
Can This 1 Thing Hurt Vaxart?
Is Vaxart the Next Moderna?
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vaxart
Industry
Biotechnology
Sector
Health CareEmployees
74
CEO
Steven Lo
Website
vaxart.comHeadquarters
South San Francisco, CA 94080, US
VXRT Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
15%
Net Income Margin
15%
Return on Equity
53%
Return on Capital
37%
Return on Assets
21%
Earnings Yield
26.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$136.15M
Shares Outstanding
242.04M
Volume
177.40K
Avg. Volume
419.79K
Financials (TTM)
Gross Profit
$237.26M
Operating Income
$18.07M
EBITDA
$28.21M
Operating Cash Flow
$7.71M
Capital Expenditure
-$145.00K
Free Cash Flow
$7.57M
Cash & ST Invst.
$63.81M
Total Debt
$8.99M
Vaxart Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$39.23M
+87.9%
Gross Profit
$39.23M
+87.9%
Gross Margin
100.00%
N/A
Market Cap
$136.15M
N/A
Market Cap/Employee
$1.30M
N/A
Employees
105
N/A
Net Income
$5.18M
+133.2%
EBITDA
$6.84M
+155.8%
Quarterly Fundamentals
Total Cash
$61.02M
+45.5%
Total Debt
$7.97M
-52.6%
Accounts Receivable
$57.57M
+257.1%
Inventory
$0.00
N/A
Long Term Debt
$5.44M
-59.9%
Short Term Debt
$2.53M
-22.3%
Return on Assets
20.60%
N/A
Return on Invested Capital
36.99%
N/A
Free Cash Flow
-$2.50M
+74.3%
Operating Cash Flow
-$2.05M
+78.6%